Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment.
Michael Cronquist ChristensenRoger S McIntyreIoana FloreaHenrik LoftAndrea FagioliniPublished in: CNS spectrums (2021)